findmyKOL
Clinical trialNCT00643994CompletedInterventional

CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution

SponsorAccuray IncorporatedEnrollment379Cancer of the ProstateProstate CancerProstate NeoplasmsProstatic CancerProstatic Neoplasms
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • St. Joseph'S Hospital and Medical Center

    Phoenix, Arizona, United States

  • Scripps Cancer Center - Cyberknife of Southern California at Vista

    La Jolla, California, United States

  • the Cyberknife at Newport Diagnostic Center

    Newport Beach, California, United States

  • Georgetown University

    Washington D.C., District of Columbia, United States

  • Coastal Cyberknife and Radiation Oncology

    Ft. Pierce, Florida, United States

  • Jupiter Medical Center & Cyberknife Center of Palm Beach

    Jupiter, Florida, United States

  • Northwest Community Hospital

    Arlington Heights, Illinois, United States

  • Community Cancer Center

    Normal, Illinois, United States

  • Central Baptist Hospital

    Lexington, Kentucky, United States

  • Franklin Square Hospital Center

    Baltimore, Maryland, United States

  • Sinai Hospital of Baltimore

    Baltimore, Maryland, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • St. Joseph Mercy Hospital

    Ann Arbor, Michigan, United States

  • Lake Saint Louis Oncology

    St Louis, Missouri, United States

  • Saint Louis University

    St Louis, Missouri, United States

  • St. Mary'S Regional Medical Center

    Reno, Nevada, United States

  • Capital Health

    Trenton, New Jersey, United States

  • Hematology Oncology Associates of Central New York

    Syracuse, New York, United States

  • Virginia Hospital Center

    Arlington, Virginia, United States

  • Swedish Cancer Center

    Seattle, Washington, United States

  • Southwest Washington Medical Center

    Vancouver, Washington, United States

  • Southwest Washington Regional Cancer Center

    Vancouver, Washington, United States

  • Thedacare Appleton Medical Center

    Appleton, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2007
Primary completion
27 Jan 2021
Completion
27 Jan 2021
Last update posted
9 May 2023
Registered enrollment
379
Registry id
NCT00643994

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.